跳至主要内容
临床试验/CTRI/2025/04/084324
CTRI/2025/04/084324尚未招募不适用

To Compare the Outcomes of Accelerated Transepithelial Corneal Cross Linking using HPMC riboflavin versus riboflavin containing Vitamin E Tocopheryl Polyethylene Glycol Succinate(TPGS) in patients with progressive Keratoconus

Poppy Debbarma1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年4月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Demarcation line depth and visibility to be measured on Swept source OCT at 8 weeks after the CXL procedure

研究概览

简要总结

To compare the outcomes of accelerated transepithelial Corneal Cross Linking using HPMC riboflavin versus riboflavin containing Vitamin E Tocopheryl polyethylene glycol succinate(TPGS) in patients with progressive keratoconus. Considering the potential benefits of transepithelial CXL, the reduced time taken by

accelerated CXL without compromising the efficacy and the potency of vitamin E-TPGS

riboflavin to effectively enhance riboflavin penetration, this study aims to evaluate the

outcome of vitamin E-TPGS riboflavin in patients with progressive keratoconus.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Month(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 1.Age 18 years or above
  • Thinnest pachymetry of 360 micrometer or above on Pentacam
  • K-max of 65D or less onScheimpflug imaging with Pentacam
  • Grade 1-3 keratoconus by Belin ABCD classification on Pentacam.
  • Corrected distance visual acuity (CDVA) of less than 20/20 on the Snellen vision chart
  • Endothelial cell density of 2000 cells/mm2 or above
  • Absence of any ocular surface disorders and other active ocular allergic conditions.

排除标准

  • Presence of advanced keratoconus associated with subepithelial scarring
  • History of herpetic keratitis or recurrent corneal erosions
  • Previous corneal surgery
  • Previous history of cross linking
  • Patients who are pregnant or breast feeding.
  • Patients with autoimmune diseases.

结局指标

主要结局

Demarcation line depth and visibility to be measured on Swept source OCT at 8 weeks after the CXL procedure

时间窗: 8 weeks after the CXL procedure

procedure

时间窗: 8 weeks after the CXL procedure

次要结局

  • 1. Change in total corneal densitometry at 3 months & 6 months post CXL compared(to pre CXL values)
  • 2. Change in maximum keratometry(Kmax) 3 months & 6 months after CXL(compared to pre CXL values)
  • 3. Change in total corneal Higher order aberrations at 3 months & 6 months(3 months & 6 months)

研究者

发起方
Poppy Debbarma
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Poppy Debbarma

Post Graduate Institute of Medical Education and Research

研究点 (1)

Loading locations...

相似试验